Rationale for the use of botulinum toxin type a in the complex therapy of cerebral palsy in children

Abstract

At present, the issue of children being born with cerebral palsy is becoming a serious medical and sociological problem; according to statistics, out of 1000 children, 3 are affected. In recent years, there has been no tendency toward a decrease in the incidence of cerebral palsy, therefore the medical aspects of rehabilitation of children with disabilities are given one of the priority positions. The aim of the study: To investigate the clinical and neurophysiological (electroneuromyographic) application of botulinum therapy in the complex rehabilitation of spastic forms of cerebral palsy in comparison with healthy patients. Clinical observations were performed on 144 children with spastic forms of cerebral palsy, and injections of botulinum neurotoxin type A were administered. For comparison of the functional state, neurophysiological examination (ENMG and HRV) was also conducted in 50 healthy children